Dr. Lauren Chung is the founder and CEO of MINLEIGH LLC, identifying, evaluating and partnering with companies for investments and various strategic, operational, and commercial opportunities. Dr. Chung has 20 years of healthcare investment management, investment banking, and advisory experience. Dr. Chung was a Managing Director in Healthcare Research at WestPark Capital. Previously, Dr. Chung was a Co-Founder of Tokum Capital Management, a global healthcare fund, which merged with Perella Weinberg Partners. Prior to that, Dr. Chung managed healthcare investment portfolios at RBR Capital, Kingdon Capital, and Pequot Capital. Earlier in her career, Dr. Chung was a recognized research scientist conducting cutting edge research in neurodegenerative and genetic disorders at Massachusetts General Hospital/Harvard Medical School and Boston Children’s Hospital. Dr. Chung has published many leading peer-reviewed scientific journals. Dr. Chung serves as a board member in healthcare companies. Dr. Chung holds a Ph.D. in Neuropathology from Columbia University-College of Physicians & Surgeons, and a BA with honors in Biochemistry and Economics from Wellesley College. She holds a Corporate Director Certificate from Harvard Business School.